COs from patients with sporadic ALS exhibited increased TDP-43 aggregates and pathology six weeks earlier than controls, suggesting that unknown factors in patients with ALS make them more susceptible to TDP-43 pathology. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.